GlassScriptPhysician profile
Edward J Morris
NPI 1619914991
$2,264.92
in general payments reported to CMS, 2019-2025
31 companies · $632 in 2025
The $632 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50.62 · 2020: $23.50 · 2021: $255 · 2022: $434 · 2023: $236 · 2024: $634 · 2025: $632.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,501.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $372.33 | 2021-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Assurity |
| Novartis Pharmaceuticals Corporation | $299.59 | 2022-2025 | |
| Amgen INC. | $184.94 | 2021-2025 | Repatha, Repatha |
| Abiomed | $137.94 | 2025 | |
| Merck Sharp & Dohme LLC | $114.36 | 2021-2025 | Verquvo, Capvaxive |
| Novo Nordisk INC | $101.52 | 2022-2025 | Wegovy, Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $101.25 | 2022-2025 | Farxiga, Andexxa |
| Pfizer INC. | $97.56 | 2022-2024 | |
| Alnylam Pharmaceuticals INC. | $86.73 | 2023-2025 | Onpattro |
| Boston Scientific Corporation | $84.66 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $73.47 | 2024-2025 | Camzyos |
| Daiichi Sankyo INC. | $71.13 | 2025 | Injectafer |
| Silk Road Medical, INC. | $52.11 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $49.83 | 2022-2023 | Opsumit |
| Regeneron Healthcare Solutions, INC. | $42.22 | 2024-2025 | Evkeeza |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vivaquant INC, Dba Rhythm Express | $41.80 | 2024 | Rhythm Express |
| Angiodynamics, INC. | $38.88 | 2025 | Alphavac |
| Sanofi-Aventis U.S. LLC | $35.81 | 2023 | |
| Medtronic, INC. | $34.30 | 2022 | |
| Irhythm Technologies, INC. | $31.55 | 2024 | Zio Monitor, Zio Xt Patch |
| Bayer Healthcare Pharmaceuticals INC. | $30.37 | 2021-2025 | |
| Astellas Pharma US INC | $28.98 | 2019-2021 | |
| Bracco Diagnostics INC. | $23.50 | 2020 | |
| Cvrx, INC. | $23.00 | 2024 | Barostim Neo System |
| Baxter Healthcare | $20.06 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Kestra Medical Technology Services, INC. | $17.91 | 2024 | Assure Wcd |
| Scpharmaceuticals INC. | $17.45 | 2024 | |
| Philips North America LLC | $17.14 | 2024 | (Ck4) Mcot |
| Chiesi USA, INC. | $13.57 | 2023 | Kengreal |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.68 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $9.28 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.